Why are steroids given for aphthous ulcers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Steroids for Aphthous Ulcers: Rationale and Approach

Topical corticosteroids are considered a first-line treatment for aphthous ulcers because they effectively reduce inflammation, decrease pain, and promote faster healing by suppressing the local immune response that contributes to ulcer formation and persistence. 1

Mechanism of Action

Corticosteroids work in aphthous ulcers by:

  • Suppressing local inflammation through inhibition of inflammatory mediators
  • Reducing pain by decreasing inflammatory processes
  • Promoting faster healing by modulating the immune response
  • Preventing recurrence when used appropriately

Treatment Algorithm

First-Line Treatment

  • Topical corticosteroids: 0.1% triamcinolone acetonide in orabase, applied 2-4 times daily until healing (typically within 7-14 days) 1
    • Alternative options include:
      • Clobetasol 0.05% ointment
      • Betamethasone sodium phosphate
      • Fluticasone propionate
      • Dexamethasone ointment (shown to significantly reduce ulcer size and pain compared to placebo) 2

Application Method

  1. Dry the affected area
  2. Apply a small amount of corticosteroid directly to the ulcer
  3. Apply after meals and before bedtime
  4. Continue until healing occurs (typically 7-14 days)

For Severe or Recurrent Cases

  • For ulcers that don't respond to topical treatments:
    • Consider short courses of systemic corticosteroids 1
    • Consider colchicine or pentoxifylline as steroid-sparing alternatives 3
    • Thalidomide is highly effective but should be reserved for severe cases due to toxicity concerns 3

Clinical Evidence

Research demonstrates the efficacy of corticosteroids for aphthous ulcers:

  • Dexamethasone ointment showed significant reduction in ulcer size (7.167 ± 6.3415 mm² vs 4.346 ± 7.0666 mm² with placebo) and pain levels (5.623 ± 1.9570 vs 4.940 ± 2.2449) with a healing ratio of 83.33% compared to 54.70% with placebo 2
  • Triamcinolone acetonide ointment demonstrated superior efficacy (86.7% positive response) compared to alternative treatments like phenytoin syrup (53.3% positive response) 4

Important Considerations and Precautions

  • Duration of use: Limit corticosteroid use to short durations (generally <8-12 weeks) to avoid adverse effects 5
  • Monitoring: Watch for signs of secondary infection, as steroids may mask infection or suppress immune response
  • Contraindications: Exercise caution in patients with:
    • Active viral, fungal, or bacterial infections
    • Immunocompromised status
    • History of steroid-induced complications

Adjunctive Measures

While using corticosteroids, recommend:

  • Good oral hygiene with soft toothbrush and mild non-foaming toothpaste
  • Avoiding triggers like hard, acidic, spicy, or salty foods
  • Avoiding toothpastes containing sodium lauryl sulfate
  • Limiting alcohol and carbonated drinks 1
  • Using topical anesthetics (like lidocaine viscous 2% solution) for pain management 1

When to Refer or Consider Alternative Diagnoses

  • If ulcers persist beyond 2 weeks despite treatment
  • For ulcers associated with systemic symptoms
  • When ulcers are unusually large or numerous
  • If there's suspicion of malignancy (induration, fixation, unexplained bleeding)

Proper use of topical corticosteroids represents an evidence-based approach to managing aphthous ulcers that effectively addresses pain, promotes healing, and improves quality of life for affected patients.

References

Guideline

Oral Health Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment strategies for recurrent oral aphthous ulcers.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.